TABLE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 2. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR VITAMIN AND DIETARY SUPPLEMENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR COUGH AND COLD PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ANALGESICS, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GASTROINTESTINAL PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SLEEP AIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTIC PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR WART REMOVERS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR MOUTH CARE PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OPHTHALMIC PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR BOTANICALS, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ANTACIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SMOKING CESSATION PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR FEMININE CARE, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER CATEGORIES, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 17. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR TABLETS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR HARD CAPSULES, BY REGION, 2016-2023 ($MILLION)
TABLE 19. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR POWDERS, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OINTMENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SOFT CAPSULES, BY REGION, 2016-2023 ($MILLION)
TABLE 22. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR LIQUIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER DOSAGE FORMS, BY REGION, 2016-2023 ($MILLION)
TABLE 24. GLOBAL OVER THE COUNTER DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 25. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR BRANDED DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 26. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GENERIC DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 27. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 28. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR PHARMACIES, BY REGION, 2016-2023 ($MILLION)
TABLE 29. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR VITAMIN AND HEALTH FOOD STORES, BY REGION, 2016-2023 ($MILLION)
TABLE 30. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ONLINE PHARMACY, BY REGION, 2016-2023 ($MILLION)
TABLE 31. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GROCERY STORES, BY REGION, 2016-2023 ($MILLION)
TABLE 32. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER DISTRIBUTION CHANNELS, BY REGION, 2016-2023 ($MILLION)
TABLE 33. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 35. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 36. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 37. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 38. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY END USE, 2016-2023 ($MILLION)
TABLE 39. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 40. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 41. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 42. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 43. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 49. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 50. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 51. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 52. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 53. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 54. PFIZER: COMPANY SNAPSHOT
TABLE 55. PFIZER: OPERATING SEGMENTS
TABLE 56. NOVARTIS: COMPANY SNAPSHOT
TABLE 57. NOVARTIS: OPERATING SEGMENTS
TABLE 58. ROCHE: COMPANY SNAPSHOT
TABLE 59. ROCHE: OPERATING SEGMENTS
TABLE 60. MERCK: COMPANY SNAPSHOT
TABLE 61. MERCK: OPERATING SEGMENTS
TABLE 62. SANOFI: COMPANY SNAPSHOT
TABLE 63. SANOFI: OPERATING SEGMENTS
TABLE 64. JOHNSON: COMPANY SNAPSHOT
TABLE 65. JOHNSON: OPERATING SEGMENTS
TABLE 66. GILEAD: COMPANY SNAPSHOT
TABLE 67. GILEAD: OPERATING SEGMENTS
TABLE 68. GSK: COMPANY SNAPSHOT
TABLE 69. GSK: OPERATING SEGMENTS
TABLE 70. BAYER: COMPANY SNAPSHOT
TABLE 71. BAYER: OPERATING SEGMENTS
TABLE 72. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 73. ASTRAZENECA: OPERATING SEGMENTS
LIST OF FIGURE
FIGURE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 13. U.S. OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 16. UK OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 17. FRANCE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 19. ITALY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 20. SPAIN OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 22. JAPAN OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 23. CHINA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 25. AUSTRALIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 28. ARGENTINA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 30. SAUDI ARABIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 31. SOUTH AFRICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 32. REST OF LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 33. PFIZER: NET SALES, 2014-2016 ($MILLION)
FIGURE 34. PFIZER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 35. PFIZER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 36. NOVARTIS: NET SALES, 2014-2016 ($MILLION)
FIGURE 37. NOVARTIS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 38. NOVARTIS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 39. ROCHE: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. ROCHE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 41. ROCHE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 44. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. SANOFI: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. SANOFI: REVENUE BY SEGMENT, 2016 (%)
FIGURE 47. SANOFI: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. JOHNSON: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. JOHNSON: REVENUE BY SEGMENT, 2016 (%)
FIGURE 50. JOHNSON: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 51. GILEAD: NET SALES, 2014-2016 ($MILLION)
FIGURE 52. GILEAD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 53. GILEAD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 54. GSK: NET SALES, 2014-2016 ($MILLION)
FIGURE 55. GSK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 56. GSK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 57. BAYER: NET SALES, 2014-2016 ($MILLION)
FIGURE 58. BAYER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 59. BAYER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 60. ASTRAZENECA: NET SALES, 2014-2016 ($MILLION)
FIGURE 61. ASTRAZENECA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 62. ASTRAZENECA: REVENUE BY GEOGRAPHY, 2016 (%)
